Jump Financial LLC lowered its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 74.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 7,155 shares of the company's stock after selling 20,891 shares during the period. Jump Financial LLC's holdings in Cardinal Health were worth $846,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently modified their holdings of CAH. Norges Bank purchased a new stake in shares of Cardinal Health in the 4th quarter valued at $246,748,000. Bank of Nova Scotia grew its holdings in shares of Cardinal Health by 1,142.4% in the fourth quarter. Bank of Nova Scotia now owns 545,313 shares of the company's stock worth $64,494,000 after purchasing an additional 501,421 shares during the last quarter. Raymond James Financial Inc. bought a new stake in Cardinal Health during the 4th quarter valued at $45,115,000. Renaissance Group LLC lifted its holdings in Cardinal Health by 4,375.6% in the 4th quarter. Renaissance Group LLC now owns 265,044 shares of the company's stock worth $31,347,000 after buying an additional 259,122 shares during the period. Finally, Federated Hermes Inc. raised its stake in Cardinal Health by 55.2% in the fourth quarter. Federated Hermes Inc. now owns 578,367 shares of the company's stock worth $68,403,000 after buying an additional 205,818 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have recently weighed in on CAH shares. Evercore ISI upgraded Cardinal Health from an "in-line" rating to an "outperform" rating and set a $140.00 price target for the company in a report on Tuesday, January 7th. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 4th. Bank of America boosted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Argus set a $148.00 price objective on Cardinal Health in a report on Tuesday, February 4th. Finally, TD Cowen raised Cardinal Health from a "hold" rating to a "buy" rating and increased their target price for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Four research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $140.86.
Check Out Our Latest Analysis on CAH
Cardinal Health Price Performance
Shares of NYSE CAH traded up $1.80 during mid-day trading on Friday, reaching $137.64. The company's stock had a trading volume of 1,804,029 shares, compared to its average volume of 2,185,108. The stock has a fifty day moving average of $130.82 and a two-hundred day moving average of $123.95. The firm has a market capitalization of $33.25 billion, a PE ratio of 25.68, a P/E/G ratio of 1.49 and a beta of 0.61. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $139.50.
Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st were issued a $0.5056 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $2.02 annualized dividend and a dividend yield of 1.47%. Cardinal Health's dividend payout ratio (DPR) is 37.69%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.